GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Sale Of Business

ENCell Co (XKRX:456070) Sale Of Business : ₩0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Sale Of Business?

ENCell Co's sale of business for the three months ended in Dec. 2023 was ₩0 Mil. It means ENCell Co gained ₩0 Mil from selling business. ENCell Co's sale of business for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Dec. 2022 ), ENCell Co gained the same money from selling business in Dec. 2023 (₩0 Mil).


ENCell Co Sale Of Business Historical Data

The historical data trend for ENCell Co's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Sale Of Business Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sale Of Business
- - - -

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Dec23
Sale Of Business - - - -

ENCell Co Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENCell Co Sale Of Business Related Terms

Thank you for viewing the detailed overview of ENCell Co's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


ENCell Co Business Description

Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines